Skip to content
Topics
Stories

There aren’t enough ventilators and hospital beds. Anti-trust laws have a lot to do with it.

People in this story

26 March 2020, Mecklenburg-Western Pomerania, Schwerin: A mobile ventilator is located in the emergency room of the Helios Clinic. The Helios Clinic is preparing for an increase in corona cases. Photo by: Jens B'ttner/picture-alliance/dpa/AP Images

Around the world, ventilators—a life-saving medical device that keeps air flowing into the lungs of a patient who is unable to breathe—are a scarce resource in hospitals and clinics where they’re used to treat those infected with the COVID-19 virus.

The machines are expensive, complex, and they take a long time to make. They’re also produced by only a handful of manufacturers, among them Medtronic, a medical equipment company that specializes in such devices. In response to the pandemic, the company has agreed to nearly double its production capacity, and recently offered to share its ventilator technology with other companies in order to accelerate production.

But if the antitrust laws regulating mergers and acquisitions by the Federal Trade Commission had been more stringent a few years ago, says economist John Kwoka, there wouldn’t be such a limited number of suppliers dominating the ventilator market, which as a result has left us vulnerable to a shortage during a public health emergency.

Continue reading at News@Northeastern.

More Stories

Racial justice protests were not a major cause of COVID-19 infection surges, new national study finds

08.11.2020

Here’s what could happen if the U.S. suspends federal pandemic unemployment benefits

08.10.2020

Black women asked their party for what they wanted. What happens next?

08.13.20
In the News